Applied Evidence

How to meet the challenges of managing patients with IBS

Author and Disclosure Information

 

References

Consider a low-FODMAP diet and soluble fiber as initial treatment for all IBS patients.

Modification of intestinal microbiota. Understanding the difference between prebiotics and probiotics is important when considering treatment for IBS. Prebiotics are foods or dietary supplements that generate changes in the composition and activity of intestinal microbiota. Probiotics are live microorganisms that can improve intestinal health.3

A meta-analysis of 729 IBS patients found that prebiotics do not reduce gastrointestinal symptoms or improve the quality of life of IBS patients.36 Evidence supporting the benefit of probiotics is favorable; however, data in these studies have significant heterogeneity. Several meta-analyses studied the benefits of Lactobacillus spp and Bifidobacterium spp in alleviating IBS symptoms. The studies found improvement in abdominal pain, bloating and distention, and flatulence.3,37-40 Consider recommending probiotics for all IBS patients; for some, however, the high cost of some of these products might be an obstacle.

Consider recommending probiotics for all IBS patients, although high cost might be an obstacle for some.

Researchers are also studying the use of fecal microbiota transplantation (FMT) to treat IBS. Studies have evaluated the delivery of FMT orally (as capsules) and endoscopically. Evidence does not show improvement in global IBS symptoms with FMT. More studies, with larger sample populations, are needed.41-43

Antispasmodic medications and peppermint oil. Antispasmodic medications have been considered a mainstay therapy for IBS because of their effect on intestinal dysmotility. Hyoscine and dicyclomine are commonly used. Meta-analyses have shown improvement in global symptoms and abdominal pain, but effects were modest.3,44 Use this class of drugs as first-line treatment for mild IBS symptoms.

Continue to: Peppermint oil has been...

Pages

Recommended Reading

Few poorly prepped colonoscopies repeated within 1 year
MDedge Family Medicine
Drink up: Large study confirms coffee beneficial to liver health
MDedge Family Medicine
Better COVID-19 outcomes confirmed in TNF inhibitor users
MDedge Family Medicine
Most infant formula trials lack transparency, carry high risk of bias: Systematic review
MDedge Family Medicine
A pill for C. difficile works by increasing microbiome diversity
MDedge Family Medicine
Stool samples meet gastric biopsies for H. pylori antibiotic resistance testing
MDedge Family Medicine
After POEM, FLIP matches HRM for measuring patient response
MDedge Family Medicine
AGA Clinical Practice Update: Managing pain in gut-brain interaction disorders
MDedge Family Medicine
Tips and tools to help refine your approach to chest pain
MDedge Family Medicine
Risankizumab has early and lasting benefits in Crohn’s disease
MDedge Family Medicine